Controversies in the Screening of Hepatitis C Virus Among First-Degree Family Members of the Affected Patients

authors:

avatar Parivash Davoodian ORCID 1 , * , avatar Hamidreza Mahboobi 1

Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
Hepatitis Monthly: Vol.18, issue 3; e45233
published online: February 5, 2017
article type: Letter
received: December 31, 2016
revised: January 23, 2017
accepted: January 31, 2017
DOI: https://doi.org/10.5812/hepatmon.45233

how to cite: Davoodian P, Mahboobi H. Controversies in the Screening of Hepatitis C Virus Among First-Degree Family Members of the Affected Patients. Hepat Mon. 2018;18(3):e45233. https://doi.org/10.5812/hepatmon.45233.

References

  • 1.

    Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, et al. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepat Mon. 2016;16(8). ee40959. [PubMed ID: 27799966]. https://doi.org/10.5812/hepatmon.guideline.

  • 2.

    Mousavi SF, Moosavy SH, Alavian SM, Eghbali H, Mahboobi H. Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran. Hepat Mon. 2013;13(12). ee14324. [PubMed ID: 24403914]. https://doi.org/10.5812/hepatmon.14324.

  • 3.

    Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepat Mon. 2016;16(4). ee37089. [PubMed ID: 27275164]. https://doi.org/10.5812/hepatmon.37089.

  • 4.

    Alavian SM, Rezaee-Zavareh MS. The Middle East and hepatitis C virus infection: does it need special attention? Lancet Infect Dis. 2016;16(9):1006-7. [PubMed ID: 27684342]. https://doi.org/10.1016/S1473-3099(16)30264-X.

  • 5.

    Kargar Kheirabad A, Bahri F, Kargar M, Ghasemzadeh I. Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran. Hepat Mon. 2016;16(10). ee40375. [PubMed ID: 27882069]. https://doi.org/10.5812/hepatmon.40375.

  • 6.

    Makiani MJ, Davoodian P, Abedi F, Hossini M, Zare S, Rahimi S, et al. AIDS and hepatitis B and C high risk behaviors among 15 to 45 years old individuals in Bandar Abbas (Iran) in 2012. Electron Physician. 2014;6(3):884-9. [PubMed ID: 25763163]. https://doi.org/10.14661/2014.883-889.

  • 7.

    WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. Geneva; 2016.

  • 8.

    Moezzi M, Imani R, Karimi A, Pourheidar B. Hepatitis C Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province of Iran in 2013. J Clin Diagn Res. 2015;9(10):LC13-7. [PubMed ID: 26557546]. https://doi.org/10.7860/JCDR/2015/14986.6694.

  • 9.

    Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Rekacewicz C, Tregouet DA, et al. Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut. 2008;57(9):1268-74. [PubMed ID: 18480169]. https://doi.org/10.1136/gut.2007.140681.